BOSTON SCIENTIFIC CORP 8-K

What Happened

• Boston Scientific Corporation filed a Form 8-K (Item 5.02) reporting that director Yoshiaki Fujimori informed the company on February 2, 2026 that he will not stand for re-election at the company’s 2026 Annual Meeting of Stockholders.
• Mr. Fujimori has served on the Board since July 2016 and is currently chair of the Risk, Science and Technology Committee. He will continue to serve as a director and in his committee roles until the 2026 Annual Meeting. The filing notes his decision is not the result of any disagreement with the company.

Key Details

• Notice given: February 2, 2026; 8-K filed February 5, 2026.
• Board tenure: director since July 2016.
• Committee role: current chair of the Risk, Science and Technology Committee; will retain duties until the 2026 Annual Meeting.
• Board action: the Board and Nominating & Governance Committee will review board size/composition and consider whether to add directors after his departure.

Why It Matters

• Board composition change: investors should note an upcoming open board seat and possible change in committee leadership, which can affect oversight of risk, science and technology matters.
• Governance signal: the company states the departure is voluntary and not due to any disagreement, suggesting no disclosed governance dispute.
• Next steps: shareholders may see a director nomination or appointment ahead of or following the 2026 Annual Meeting as the Board evaluates its composition.